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In Brief
Hosts have many defenses that protect against parasites. In nature, two distinct defense strategies are found: constitutive defenses (always active) and inducible defenses (triggered by parasites). Here, Westra et al. show that parasite exposure drives the evolution of these two distinct strategies.
RESULTS AND DISCUSSION
To examine factors that can explain the relative investment in constitutive and inducible defenses, we constructed a mathematical model of hosts and obligately killing parasites that incorporates the evolution of immunity and epidemiology. Our model relies on two assumptions concerning the costs associated with immunity: (1) constitutive defense is associated with a fixed (constitutive) cost that is independent of parasite levels and (2) inducible defense is associated with an infectioninduced cost that increases with increasing frequencies of infection. This is incorporated in our model as follows: constitutive defense prevents infection and comes with a constitutive cost such that high defense reduces host birth rate. Inducible defense increases recovery rate and involves an induced immunopathological cost such that increased defense increases death rate.
First, we investigated how resource availability affects the relative investment in constitutive and inducible defenses. Resource availability is an ecologically relevant factor that, among a range of possible effects, impacts population density, which in turn impacts parasite abundance. Evolutionary analysis (see the Supplemental Experimental Procedures) clearly shows that constitutive defense is selected for in high resource environments, whereas inducible defense is favored at low resources ( Figure 1A ). We hypothesize that this effect emerges from the epidemiology of the system with more infections under nutrient-rich conditions, which leads to higher emergent costs to inducible defenses. As such, our model, along with predictions of more specific previous theory [23, 24] , suggests that infection risk may be a general mechanism that determines the relative investment in constitutive and inducible defense.
We tested this theoretical prediction using bacteria and their phages. As a model system we used Pseudomonas aeruginosa PA14, which has a type I-F CRISPR-Cas (clustered regularly interspaced short palindromic repeat, CRISPR associated) system ( Figure S1A ) [25] , and phage DMS3vir [26] , a mu-like phage [27] . First, we examined the evolution of bacteriophage immunity mechanisms under high-and low-resource conditions. We challenged wild-type (WT) P. aeruginosa PA14 with 10 4 plaque-forming units (pfu) NTf (non-targeted phage; DMS3vir), which is not a priori targeted by the WT type I-F CRISPR-Cas system [26] . In agreement with the theoretical model, bacteria primarily evolved immunity by loss of the phage receptor (loss of the pilus; surface modification [sm]) in nutrient-rich medium (LB) at 3 days post-infection (dpi) but evolved immunity by CRISPR-Cas in nutrient-limited medium (M9 supplemented with 0.2% glucose) ( Figure 1B ).
To formally check for CRISPR-mediated immunity, we sequenced both CRISPR loci (CRISPR1 and CRISPR2) of 144 independent WT clones that were infected in nutrient-limited medium with 10 4 pfu NTf and that were isolated at 3 and 7 dpi
(from six replicate experiments). CRISPR2 was more active than CRISPR1 (Figures 2A-2C ) and the number of acquired spacers increased over time ( Figure 2C ). Mapping of novel spacers onto the phage genome revealed clustering of protospacers around position 28,000 on the phage genome. Protospacers upstream and downstream of this position were typically located on the positive and negative strand, respectively ( Figure 2D ), a typical feature of primed spacer acquisition in type I-F CRISPR-Cas systems [28] that most likely resulted from the partial match between spacer 1 of CRISPR2 and gene 42 (position 27,616-28,572) on the phage genome [29] . Sequence analysis showed that nearly all acquired spacers were unique (97.2% ± 2.5% at 3 dpi and 97.9% ± 3.1% at 7 dpi; Table S1 ). In agreement with earlier studies [30] , protospacers were invariably flanked by a GG protospacer-adjacent motif (PAM) ( Figure 2E ). PAM sequences play an important role both in spacer acquisition [31, 32] and in the interference stage of the immune response [33] . These data corroborate previously reported molecular features of acquired immunity by type I-F CRISPR-Cas systems. Our model suggests that differential phage exposure might be the driver of investment into constitutive versus inducible immunity; hence, we examined bacterial and phage population densities in the two types of growth media. In M9, bacteria reached 10-fold lower densities compared to LB in the absence of phage ( Figure S1B ) and had longer generation times (57 ± 6 min in M9 versus 28 ± 2 min in LB). Furthermore, phage accumulation was slower in M9 compared to LB, and phage densities were approximately 100-fold lower throughout the measurements (Figure S1C) . Lower host and parasite densities reduce the infection risk (determined by the product of their densities; see the Supplemental Experimental Procedures). When we varied parasite production (burst size) in our model, we found that higher parasite production selected for constitutive defense ( Figure S1D ), which further indicated that infection risk may drive the evolution of the immune strategies.
To experimentally verify that CRISPR-Cas and sm-mediated immunity indeed results from different phage exposures (and Error bars correspond to 95% confidence intervals (CIs). Bacteria were grown in LB (high resources) or M9 (low resources). See also Figure S1 .
not from other differences between the LB and M9 growth media), we increased phage exposure in M9. Strikingly, a gradual increase in phage exposure from 10 4 to 10 7 and 10 9 pfu NTf was associated with decreased evolution of CRISPRCas-mediated immunity and increased sm-mediated immunity ( Figure pfu NTf, the WT strain evolved higher levels of sm-mediated immunity when grown in 60 ml volume (high phage density) compared to 6 ml (low phage density, but same number of phages) ( Figure 3B ; F 1,10 = 25.2, p = 0.0005; Figure S2B ; F 1,10 = 12.02, p = 0.006). These data clearly show that infection risk directly impacts the relative investment in constitutive and inducible defenses. We next measured the relative fitness associated with either immunity mechanism by competing the WT strain against a sm mutant in the presence of Tf (targeted phage; DMS3mvir), which is targeted by the WT CRISPR-Cas system (i.e., both strains are resistant) [26] . An increase in the frequency of one bacterial strain over another serves as a direct measure of relative fitness. In agreement with the data above, CRISPR-Cas-mediated immunity provided a fitness advantage over sm-mediated immunity when phage exposure was low (relative fitness > 1 upon infection with 10 4 and 10 7 pfu Tf), and vice versa when exposure was high (relative fitness < 1 upon infection with 10 9 pfu Tf) ( Figure 3C ; T 5 = 5.98, T 5 = 11.52, T 5 = 430; p < 0.005 in all cases; Figure S2C ). There are three possible causes for the competitive disadvantage of CRISPR-Cas versus surface modification at high phage exposure: CRISPR-Cas could (1) provide partial immunity, (2) be overcome more readily by phage evolution, or (3) be associated with greater fitness costs than constitutive immunity, as assumed in our model. We first examined whether differences exist in the associated resistance levels by exposing bacteria with the two types of immunity to high concentrations of phage. In agreement with the previously reported high survival rates upon phage exposure of CRISPR immune bacteria [33] , we did not detect any mortality in either case ( Figure S2D ), which suggested that the immunity levels were not different. Although we cannot exclude the possibility that differences in mortality rates exist that fall within the error of the method, further experiments suggest that partial immunity is unlikely to explain our results. Of the acquired spacers, 67% ± 8% (3 dpi) and 59% ± 11% (7 dpi) target the negative strand of the phage, revealing a strand bias at 3 dpi (T 5 = 4.14; p = 0.0089), but not at 7 dpi (T 5 = 1.50; p = 0.19).
(E) Weblogo of protospacers and 15 bp flanking sequence reveals a protospacer-adjacent motif (PAM), generated using the WebLogo online software (http:// weblogo.berkeley.edu). Bacteria were grown in M9. See also Figure S2 .
CRISPR-mediated immunity led to a 2-fold reduction in phage titers after 2 hr ( Figure S2E ), along with a latent period of 80 min and a phage burst size of approximately 88 ± 8 (data not shown), suggesting that at least 99.4% of the bacteria with CRISPR-mediated immunity are phage resistant (fraction of phage present after a single infection round = burst size 3 fraction of sensitive bacteria).
As a result of the sequence specificity of CRISPR-Casmediated immunity, phages can readily evolve to overcome this type of immunity [33, 34] . As genetic diversity increases with the phage population size, this could contribute to reduced fitness associated with CRISPR-Cas at high phage exposure. Phages that carry point mutations that result in escape from CRISPR-Cas could indeed be readily detected ( Figure S2F ), while we could not detect pili-binding phages that overcome sm. To examine this in detail, we performed competition experiments between sm mutants and CRISPR-Cas-immune bacteria that have multiple spacers targeting multiple Tf loci (bacteriophage-insensitive mutant 1 [BIM1] and BIM2; Table S1 ). Because multiple spacers of BIM1 and BIM2 target Tf (two and three spacers, respectively), the phage has a reduced probability of escaping the immune response by mutation. Crucially, we found that CRISPR-Cas-mediated immunity was associated with a fitness disadvantage (relative fitness < 1) when exposed to Figure 3B , indicates that under these conditions the differential evolution of CRISPR-Cas versus sm is primarily driven by phage exposure rather than by phage genetic diversity.
Next, we examined whether sm and CRISPR-Cas are associated with constitutive and inducible costs of immunity, as assumed in the model. To examine whether sm is associated with a constitutive fitness cost, we competed two independent sm mutants (sm and sm2; Figures S3A and S3B) against WT P. aeruginosa PA14. In agreement with previous studies [35] , sm (loss of the pilus, the phage receptor) was associated with a fitness cost (relative fitness WT > 1) in the absence of phage (constitutive cost of immunity; Figures 4A and S3C ; sm, T 5 = 4.99; sm2, T 4 = 9.31; p < 0.005 in both cases). Nutrient availability can directly impact on the cost associated with immunity [36] , suggesting that the observed CRISPR evolution under nutrientlimited conditions could be purely resource driven. However, we found that the sm-associated constitutive cost was independent of resource availability (M9 versus LB) ( Figure S3D ; sm, F 1,10 = 1.76; sm2, F 1,10 = 0.36; p > 0.20 in both cases).
The inducible cost associated with CRISPR-Cas-mediated immunity was apparent from our data showing that the relative fitness of WT versus sm decreases with increasing phage exposure ( Figures 3C, S3E , and S3F; Kruskal-Wallis Test, p < 0.005 in both cases); this is because the inducible cost increases with increasing phage density due to CRISPR-Cas being elicited more frequently. By contrast, we found no constitutive cost of CRISPR-Cas-mediated immunity. When the WT P. aeruginosa strain was competed in the absence of phage against a knockout mutant (CRISPR-KO; P. aeruginosa csy3::lacZ, carrying a nonfunctional CRISPR-Cas system [26] ), we found that the WT and CRISPR-KO strains had a similar fitness ( Figure 4B ; relative fitness = 1 T 5 = 1.87; p = 0.12 at 5 days), showing that a functional CRISPR-Cas immune pathway has no detectable fitness cost when parasites are absent. To examine the fitness consequences of encoding cas genes and CRISPR loci on the genome, we also competed the CRISPR-KO strain against an isogenic strain from which the entire CRISPR-Cas system has been deleted (P. aeruginosa DCRISPR-Cas [29] ). Surprisingly, the DCRISPR-Cas strain had a lower fitness (relative fitness < 1) than the P. aeruginosa csy3::lacZ strain ( Figure S3G p < 0.0001 at 5 days), which indicates that components of CRISPR-Cas provide a fitness benefit in the absence of phage. Perhaps P. aeruginosa PA14 CRISPR-Cas functions in processes other than immunity, akin to the CRISPR loci and cas genes of other bacterial species [37] . Taken together, our data show that sm and CRISPR-Cas are associated with constitutive and inducible costs of immunity.
Our results suggest that the most likely cause for the cost of immunity associated with CRISPR-Cas is either an increase in mortality rate or reduced replication. Increased mortality could result from autoimmunity [38] [39] [40] . In addition, spacer acquisition requires opening of the bacterial genome (reviewed in [11] ) and erratic incorporation events are potentially lethal. The high number of spacer duplication events that we observed suggests that this step may be error prone (Table S1 and data not shown). Reduced replication rates could result from resources being allocated to defense that would otherwise be invested in replication. The reason why surface modification is costly is more intuitive since phage receptors are often important fitness determinants of bacteria [41] . Pili, the phage receptors in our experimental system, are important for bacterial motility [42] and biofilm formation [43] . Loss of pili has a clearly detectable cost in a natural environment, soil (data not shown). Although motility and biofilm formation are not expected to be important in an in vitro laboratory environment, our fitness analyses show that bacteria lacking pili suffered a significant competitive cost.
In nature, high parasite densities may contribute to the existence of non-functional or degenerated CRISPR-Cas systems. This may explain, along with the suggestion that the CRISPR-Cas system is less effective in the face of rapidly evolving viruses, why half of the bacteria lack CRISPR-Cas, whereas the system is almost ubiquitous among Archaea, which typically have lower population densities and less exposure to viruses [44] . Indeed, our study shows that carrying a functional CRISPR-Cas system provides a selective advantage under nutrient-limited conditions in the presence of NTf (relative fitness > 1; Figure S4A ; 10 4 pfu, T 5 = 5.0; 10 7 pfu, T 5 = 6.7; 10 9 pfu, T 5 = 4.7; p < 0.006), but not under nutrient-rich conditions (relative fitness = 1; Figure S4B ; T 5 = 0.44; p = 0.67). Our findings also help to explain the apparent discrepancy between laboratory studies and correlational studies of natural populations. The latter are typically associated with lower bacterial and phage densities and typically report highly diverse CRISPR loci that are consistent with a key role in conferring phage immunity [21, 45, 46] . By contrast, the predominantly reported mechanism of evolving phage immunity under (nutrient-rich) laboratory conditions is by modification or masking of surface receptors [41] , even when a CRISPR-Cas adaptive immune system is present [26] and despite the large competitive cost generally associated with surface modification [10, 35] .
More generally, the theory and the data together suggest that parasite exposure is likely to be a key factor in driving the evolution of constitutive and inducible defenses in nature. This suggests that organisms living together in large populations or parasite-rich conditions are more likely to evolve constitutive defenses, whereas low-parasite conditions select for inducible defenses. Given that most species have both types of defenses, constitutive defenses are likely to be directed at the more abundant parasite species, while inducible defenses protect against the rarer parasites. It will be fascinating to see whether changes in parasite abundance can explain the observed evolution of constitutive defense from inducible defense [2] , and vice versa [47] . Error bars correspond to 95% CIs. Bacteria were grown in LB. See also Figure S4 .
